New Medrxiv pre-print fits perfectly with Dr. Patt
Post# of 148184
(Total Views: 598)
Posted On: 07/24/2020 12:41:46 PM
New Medrxiv pre-print fits perfectly with Dr. Patterson's manuscript on Leronlimab and immune dysregulation (to the extent of my understanding).
"Cell type-specific immune dysregulation in severely ill COVID-19 patients"
https://www.medrxiv.org/content/10.1101/2020....l.pdf+html
Discusses cell trafficking in response to elevated cytokines, T-cell exhaustion and resultant lymphopenia.
"Cell type-specific immune dysregulation in severely ill COVID-19 patients"
https://www.medrxiv.org/content/10.1101/2020....l.pdf+html
Discusses cell trafficking in response to elevated cytokines, T-cell exhaustion and resultant lymphopenia.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼